Journals / İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi / 2017 / Cilt: 24 - Sayı: 1

Papillary carcinoma of the thyroid in a mature cystic teratoma of the ovary: a case report

Pages
91–93
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Struma ovarii is a rare ovarian tumor, reported as %0.5-1 of all ovarian masses and

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mature cystic teratomas (MCT) are composed of a mixture of tissues derived from all three germ layers and are the most common ovarian tumor in both adolescents and women of reproductive age.
📊
Key Findings & Data:Although most of these tumors are benign, malignant transformation of MCT occurs only in about 1-2% of cases.
💡
Conclusion & Impact:Struma ovarii is a rare ovarian tumor, reported as %0.5-1 of all ovarian masses and
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Mature cystic teratomas (MCT) are composed of a mixture of tissues derived from all three germ layers and are the most common ovarian tumor in both adolescents and women of reproductive age. Although most of these tumors are benign, malignant transformation of MCT occurs only in about 1-2% of cases. Any of the tissues within the MCT, can change malignant transformation. Struma ovarii is a rare ovarian tumor, reported as %0.5-1 of all ovarian masses and

🔖

Cite This Article

SİPAHİ, M., TOKGÖZ, V. Y., LİVAOGLU, A., KOZAN, R., ERİN, R., AGİRBAS, D. B. (2022). Papillary carcinoma of the thyroid in a mature cystic teratoma of the ovary: a case report. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi, Cilt: 24 - Sayı: 1, 91–93. https://ajindex.com/articles/549088

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Krishnamurthy A, Ramshankar V, Vaidyalingam V, Majhi U. Synchronous papillary carcinoma thyroid with malignant struma ovarii: A management dilemma. Indian J Nucl Med 2013;28:243-5. 2.Crum CP, Nucci MR, Lee KR. Germ Cell Tumors of the Ovary. In: Patricia M Baker, Esther Oliva, eds. Diagnostic Gynecologic and Obstetric Pathology, 2nd ed. Philadelphia: Saunders Elsevier 2011. P 501-539. 3.Westhoff C, Pike M, Vessey M. Benign ovarian teratomas: a population-based case-control study. Br J Cancer 1988;58(1):93-8. 4.Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol 1993;12(4):333-43. 5.Schmidt J, Derr V, Heinrich MC, Crum CP, Fletcher JA, Corless CL, et al. BRAF in papillary thyroid carcinoma of ovary (struma ovarii). Am J Surg Pathol 2007;31(9):1337-43. 6.Doganay M, Gungor T, Cavkaytar S, Sirvan L, Mollamahmutoglu L. Malignant struma ovarii with a focus of papillary thyroid cancer: a case report. Arch Gynecol Obstet 2008;277(4):371-3. 7.Nakamura N, Erickson LA, Jin L, Kajita S, Zhang H, Qian X, et al. Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma. Endocr Pathol 2006;17(3):213-23. 8.Goffredo P, Sawka AM, Pura J, Adam MA, Roman SA, Sosa JA. Malignant struma ovarii: a population-level analysis of a large series of 68 patients. Thyroid 2015;25(2):211-5. 9.Shaco-Levy R, Peng RY, Snyder MJ, Osmond GW, Veras E, Bean SM, et al. Malignant struma ovarii: a blinded study of 86 cases assessing which histologic features correlate with aggressive clinical behavior. Arch Pathol Lab Med 2012;136(2):172-8.